To explore the clinical effect of stent thrombolysis in the treatment of acute cerebral artery occlusion.

From May 2015 to May 2017, 90 patients visiting to the Taian Central Hospital with acute cerebral arterial occlusion were chosen in this prospective study. Using the random number table method we divided the patients into two groups: control group and test group; control group was treated by simple artery thrombolysis, and treatment group was gived by support bolt joint arterial thrombolysis. The efficacy of patients was compared between the two groups before and after treatment with the National Institutes of Health Neural Function Defect Scores(NIHSS), Daily Life Ability Rating Scales (ADL) scores and the safety, respectively.

Compared with that before treatment, two groups of patients showed that the NIHSS scores were decreased (P<0.05) and ADL scores were increased (P<0.05). The test group of NIHSS scores were lower than that of the control group (P <0.05), the ADL scores were higher than that of the control group (P<0.05). Recanalization in patients with the treatment group was better than that of the control group (P<0.05). The intracranial hemorrhage, symptomatic intracranial hemorrhage and the incidence of adverse events such as death within 90 days were lower than those of the control group (P<0.05), with statistically significant difference between the groups.

The stent joint artery thrombolysis in the treatment of acute cerebral artery occlusion can obviously improve the patient's blood flow state and the rate of blood vessels, reduce the incidence of intracerebral haemorrhage, and then ensure the conditions of prognosis and quality of life.